Latest Medical genetics Stories
MDA research grantee Charles Gersbach announces potentially game-changing advance in gene modification for boys and young men with DMD. Chicago, IL (PRWEB) February
SAN DIEGO, Feb.
Frost & Sullivan finds that direct to consumer genomics, which were close to absent a decade ago, are currently thriving LONDON, Feb.
DALLAS, February 21, 2015 /PRNewswire/ -- RnRMarketResearch.com announces addition of Gene Therapy Hematological Disorders Insight and Gene Therapy Metabolic Disorders
23andMe's Personal Genome Service® 510(k) Submission for Bloom Syndrome Carrier Status Test Report Granted Marketing Authority through De Novo Classification MOUNTAIN VIEW, Calif.,
Product holds potential for replacing glucocorticoids in Duchenne muscular dystrophy and other chronic inflammatory states SILVER SPRING, Md. and CHICAGO, Feb.
NEW YORK, Feb. 9, 2015 /PRNewswire/ -- A market for gene therapy exceeding $13 billion could be possible by 2025 if the technologies show success in the current trials underway.
Researchers at Nationwide Children's Hospital have developed a way to measure upper extremity movement in patients with muscular dystrophy using interactive video game technology. Their hope is to expand inclusion criteria for clinical trials to incorporate patients using wheelchairs.
- The parings of haberdine; also, any kind of fragments.